UCSF Leukemia Trial → Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
This Leukemia and Acute Lymphoblastic Leukemia study at UCSF ends December 2027.| clinicaltrials.ucsf.edu
This Leukemia and Acute Lymphoblastic Leukemia study at UCSF ends December 2027.| clinicaltrials.ucsf.edu
